Mingyu Liu

6.8k total citations · 1 hit paper
75 papers, 2.5k citations indexed

About

Mingyu Liu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Mingyu Liu has authored 75 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 20 papers in Immunology and 10 papers in Cancer Research. Recurrent topics in Mingyu Liu's work include Immune cells in cancer (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Mitochondrial Function and Pathology (5 papers). Mingyu Liu is often cited by papers focused on Immune cells in cancer (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Mitochondrial Function and Pathology (5 papers). Mingyu Liu collaborates with scholars based in China, United States and Taiwan. Mingyu Liu's co-authors include De‐Li Dong, Xin Shen, Shanliang Li, Changlin Zhen, Xinzi Zhang, Jin‐Lai Gao, Yuanyuan Wei, Irene Jarchum, Eric G. Pamer and Jing Jin and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Chemical Communications.

In The Last Decade

Mingyu Liu

72 papers receiving 2.4k citations

Hit Papers

Mitochondrial Fission Inhibitors Suppress Endothelin-1-In... 2017 2026 2020 2023 2017 200 400 600

Peers

Mingyu Liu
Li Xiao China
Lixin Ma United States
Dan Liu China
Lu Dai China
Yili Wang China
Ziwei Li China
Binod Kumar United States
Li Xiao China
Mingyu Liu
Citations per year, relative to Mingyu Liu Mingyu Liu (= 1×) peers Li Xiao

Countries citing papers authored by Mingyu Liu

Since Specialization
Citations

This map shows the geographic impact of Mingyu Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyu Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyu Liu more than expected).

Fields of papers citing papers by Mingyu Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyu Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyu Liu. The network helps show where Mingyu Liu may publish in the future.

Co-authorship network of co-authors of Mingyu Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyu Liu. A scholar is included among the top collaborators of Mingyu Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyu Liu. Mingyu Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Mingyu & Teng Teng. (2025). Exosomes: new targets for understanding axon guidance in the developing central nervous system. Frontiers in Cell and Developmental Biology. 12. 1510862–1510862. 4 indexed citations
2.
Wang, Ying, Liming Cao, Mingyu Liu, et al.. (2024). Alternative splicing of lncRNA LAIR fine‐tunes the regulation of neighboring yield‐related gene LRK1 expression in rice. The Plant Journal. 119(4). 1751–1766. 2 indexed citations
3.
Wang, Yixian, et al.. (2024). Deep Learning and Single‐Cell Sequencing Analyses Unveiling Key Molecular Features in the Progression of Carotid Atherosclerotic Plaque. Journal of Cellular and Molecular Medicine. 28(22). e70220–e70220.
4.
6.
Fu, Chun & Mingyu Liu. (2023). Genome-wide identification and molecular evolution of NAC gene family in Dendrobium nobile. Frontiers in Plant Science. 14. 1232804–1232804. 14 indexed citations
7.
Liu, Mingyu, Lulu Xie, Yuying Zhang, et al.. (2023). Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases. Cell Death and Disease. 14(1). 25–25. 18 indexed citations
8.
Chen, Ye, Weiguo Cai, Mingyue Cai, et al.. (2023). Intratumoral Lactate Depletion Based on Injectable Nanoparticles−Hydrogel Composite System Synergizes with Immunotherapy against Postablative Hepatocellular Carcinoma Recurrence. Advanced Healthcare Materials. 13(6). e2303031–e2303031. 17 indexed citations
9.
Xie, Lulu, Mingyu Liu, Mingyue Cai, et al.. (2023). Regorafenib enhances anti-tumor efficacy of immune checkpoint inhibitor by regulating IFN-γ/NSDHL/SREBP1/TGF-β1 axis in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 159. 114254–114254. 15 indexed citations
10.
Wang, Junli, Yiran Wang, Liping Yang, et al.. (2023). Establishment and characterization of Yellow River carp (Cyprinus carpio haematopterus) muscle cell line and its application to fish virology and immunology. Fish & Shellfish Immunology. 139. 108859–108859. 10 indexed citations
11.
12.
Tao, Huimin, Mingyu Liu, Yuan Wang, et al.. (2021). Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation. Frontiers in Immunology. 12. 609295–609295. 57 indexed citations
13.
Lin, Huiling, Haitian Chen, Jin‐Heng Li, et al.. (2021). Optimized Intracellular Staining Reveals Heterogeneous Cytokine Production Ability of Murine and Human Hematopoietic Stem and Progenitor Cells. Frontiers in Immunology. 12. 654094–654094. 4 indexed citations
14.
Wu, Peiling, et al.. (2020). Engineering an Optogenetic CRISPRi Platform for Improved Chemical Production. ACS Synthetic Biology. 10(1). 125–131. 44 indexed citations
15.
Wu, Chong, Jie Lin, Yulan Weng, et al.. (2020). Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma. Journal of Clinical Investigation. 130(9). 4679–4693. 51 indexed citations
16.
Wu, Chong, Mingyu Liu, Jie Lin, et al.. (2018). Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis. Journal of Clinical Investigation. 128(8). 3425–3438. 122 indexed citations
17.
Liu, Mingyu, et al.. (2018). MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. Journal of Experimental & Clinical Cancer Research. 37(1). 10–10. 60 indexed citations
18.
Li, Shanliang, Jie Yan, Yanqiu Zhang, et al.. (2016). Niclosamide ethanolamine inhibits artery constriction. Pharmacological Research. 115. 78–86. 37 indexed citations
19.
Liu, Mingyu, Sarah M. McLeod, John Wiseman, et al.. (2014). Secreted Gaussia princeps Luciferase as a Reporter of Escherichia coli Replication in a Mouse Tissue Cage Model of Infection. PLoS ONE. 9(3). e90382–e90382. 9 indexed citations
20.
Liu, Mingyu, et al.. (2012). The Legionella pneumophila EnhC Protein Interferes with Immunostimulatory Muramyl Peptide Production to Evade Innate Immunity. Cell Host & Microbe. 12(2). 166–176. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026